One of our researchers has received a prestigious election to the Academy of Medical Sciences. Professor Lucy Chappell is an NIHR Research Professor in Obstetrics at King’s College London and an honorary consultant in obstetrics at Guy’s and St Thomas’.

Professor Chappell received her Fellowship for her work on women’s health, investigating the prediction and prevention of adverse pregnancy outcomes. Her work particularly focuses on women with pre-existing co-morbidities such as chronic hypertension and chronic kidney disease, using randomised controlled trials and observational studies.

Her work on pre-eclampsia has led to improvements in the way a number of conditions are treated. For instance, last year, she led the NIHR-supported PARROT study, which showed that the PIGF test could accurately diagnose pre-eclampsia on average two days earlier than existing methods. The advance could save lives and has contributed to the NHS making the test more widely available.

During the COVID-19 pandemic, Professor Chappell has refocused her research on the treatment of pregnant women who have the condition. She is leading the recruitment of pregnant women to the RECOVERY trial. Professor Chappell wrote the Royal College of Obstetricians and Gynaecologists national guidelines for home blood pressure monitoring in pregnancy for the COVID-19 pandemic and is working with NHS England on the evaluation.

Professor Chappell said: “I am delighted to have been elected as a Fellow of the Academy of Medical Sciences. I have worked in pregnancy research for some years, aiming to make a difference to the care and outcomes for pregnant women and their families across the UK and further afield. This Fellowship reflects the thriving team science in which I am proud to play a part. I hope to continue to harness these collaborations, both to tackle the current problem of COVID-19, and more broadly to address the many unanswered research questions for pregnant women.”

Professor Chappell is also President of the Blair Bell Research Society, chair of the NIHR HTA Clinical Evaluation and Trials committee and a member of the International Society for the Study of Hypertension in Pregnancy council.

Share: